NYSE: MATVMativ Holdings Inc Stock
$8.90-0.53 (-5.62%)
Updated Feb 7, 2025
MATV Price
$8.90
Fair Value Price
N/A
Market Cap
$483.59M
52 Week Low
$8.88
52 Week High
$19.96
P/E
4.56x
P/B
0.55x
P/S
0.47x
PEG
N/A
Dividend Yield
4.49%
Revenue
$1.97B
Earnings
$107.50M
Gross Margin
18.9%
Operating Margin
8.08%
Profit Margin
5.4%
Debt to Equity
1.97
Operating Cash Flow
$125M
Beta
1.05
Next Earnings
Feb 19, 2025
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MATV's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Value
C
Growth
D
Momentum
D
Sentiment
C
Safety
C
Financials
B
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Chemical
Industry Rating
B
MATV
Ranked#24 of 54
Ranked#24 of 54
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $9.45 | A | |
| $42.63 | A | |
| $14.02 | A |
Be the first to know about important MATV news, forecast changes, insider trades & much more!
MATV News
Overview
Due Diligence Score
–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MATV scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MATV was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MATV is good value based on its earnings relative to its share price (4.56x), compared to the US market average (30.7x)
P/E vs Market Valuation
MATV is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MATV due diligence checks available for Premium users.
Valuation
MATV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
4.56x
Industry
28.85x
Market
30.7x
MATV is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MATV is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
MATV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.55x
Industry
3.3x
MATV is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MATV's financial health
Profit margin
Revenue
$498.5M
Net Income
-$20.8M
Profit Margin
-4.2%
MATV's Earnings (EBIT) of $159.50M... subscribe to Premium to read more.
Interest Coverage Financials
MATV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.6B
Liabilities
$1.7B
Debt to equity
1.97
MATV's short-term assets ($777.30M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MATV's long-term liabilities ($1.41B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MATV's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MATV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$37.6M
Investing
-$9.4M
Financing
-$4.2M
MATV's operating cash flow ($124.90M)... subscribe to Premium to read more.
Debt Coverage Financials
MATV vs Specialty Chemical Stocks
Mativ Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.